National Biodefense Science Board Public Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The National Biodefense Science Board (NBSB) will publicly meet using an online format on Thursday, November 30, 2023 (12:30 to 4:00 p.m. ET). Notice of the meeting is required under section 10(a)(2) of the Federal Advisory Committee Act (FACA). The NBSB provides expert advice and guidance to the U.S. Department of Health and Human Services (HHS) regarding current and future chemical, biological, radiological, and nuclear threats, as well as other matters related to disaster preparedness and response. The Administration for Strategic Preparedness and Response (ASPR) manages and convenes the NBSB on behalf the Secretary of HHS. The NBSB will discuss and vote on two sets of recommendations related to COVID-19 pandemic lessons, Project NextGen vaccine and therapeutic products, and disaster preparedness training. Procedures for Public Participation: The public and expert stakeholders are invited to observe the meeting. Pre-registration (Zoom) is required. Anyone may submit questions and comments to the NBSB by email (NBSB@hhs.gov) before the meeting. American Sign Language translation and Communication Access Real-Time Translation will be provided. Representatives from industry, academia, health professions, health care consumer organizations, non-federal government agencies, or community-based organizations may request up to seven minutes to speak directly to the Board. Requests to speak to the Board will be approved in consultation with the Board Chair and based on time available during the meeting. Requests to speak to the NBSB during the public meeting must be sent to NBSB@hhs.gov by close of business on November 23, 2023. Please provide the full name, credentials, official position(s), and relevant affiliations for the speaker and a brief description of the intended topic. Presentations that contain material with a commercial bias, advertising, marketing, or solicitations will not be allowed. A meeting summary will be available on the NBSB website post-meeting.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 205 (Wednesday, October 25, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 205 (Wednesday, October 25, 2023)]
[Notices]
[Page 73351]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-23532]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Biodefense Science Board Public Meeting
AGENCY: Administration for Strategic Preparedness and Response (ASPR),
Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Biodefense Science Board (NBSB) will publicly
meet using an online format on Thursday, November 30, 2023 (12:30 to
4:00 p.m. ET). Notice of the meeting is required under section 10(a)(2)
of the Federal Advisory Committee Act (FACA). The NBSB provides expert
advice and guidance to the U.S. Department of Health and Human Services
(HHS) regarding current and future chemical, biological, radiological,
and nuclear threats, as well as other matters related to disaster
preparedness and response. The Administration for Strategic
Preparedness and Response (ASPR) manages and convenes the NBSB on
behalf the Secretary of HHS. The NBSB will discuss and vote on two sets
of recommendations related to COVID-19 pandemic lessons, Project
NextGen vaccine and therapeutic products, and disaster preparedness
training.
Procedures for Public Participation: The public and expert
stakeholders are invited to observe the meeting. Pre-registration
(Zoom) is required. Anyone may submit questions and comments to the
NBSB by email (<a href="/cdn-cgi/l/email-protection#cc828e9f8e8ca4a4bfe2aba3ba"><span class="__cf_email__" data-cfemail="4709051405072f2f3469202831">[email protected]</span></a>) before the meeting. American Sign Language
translation and Communication Access Real-Time Translation will be
provided.
Representatives from industry, academia, health professions, health
care consumer organizations, non-federal government agencies, or
community-based organizations may request up to seven minutes to speak
directly to the Board. Requests to speak to the Board will be approved
in consultation with the Board Chair and based on time available during
the meeting. Requests to speak to the NBSB during the public meeting
must be sent to <a href="/cdn-cgi/l/email-protection#541a160716143c3c277a333b22"><span class="__cf_email__" data-cfemail="cc828e9f8e8ca4a4bfe2aba3ba">[email protected]</span></a> by close of business on November 23, 2023.
Please provide the full name, credentials, official position(s), and
relevant affiliations for the speaker and a brief description of the
intended topic. Presentations that contain material with a commercial
bias, advertising, marketing, or solicitations will not be allowed. A
meeting summary will be available on the NBSB website post-meeting.
FOR FURTHER INFORMATION CONTACT: CAPT Christopher Perdue; NBSB
Designated Federal Official, (202) 480-7226; <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e4aaa6b7a6a4acacb7caa3abb2">[email protected]</a>.
Dawn O'Connell,
Assistant Secretary for Preparedness and Response.
[FR Doc. 2023-23532 Filed 10-24-23; 8:45 am]
BILLING CODE 4150-37-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.